<SEC-DOCUMENT>0000950170-25-018896.txt : 20250212
<SEC-HEADER>0000950170-25-018896.hdr.sgml : 20250212
<ACCEPTANCE-DATETIME>20250212163003
ACCESSION NUMBER:		0000950170-25-018896
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250212
DATE AS OF CHANGE:		20250212

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Oculis Holding AG
		CENTRAL INDEX KEY:			0001953530
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94014
		FILM NUMBER:		25615272

	BUSINESS ADDRESS:	
		STREET 1:		BAHNHOFSTRASSE 7
		CITY:			ZUG
		STATE:			V8
		ZIP:			6300
		BUSINESS PHONE:		617-937-2423

	MAIL ADDRESS:	
		STREET 1:		BAHNHOFSTRASSE 7
		CITY:			ZUG
		STATE:			V8
		ZIP:			6300

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LSP 7 Cooperative UA
		CENTRAL INDEX KEY:			0001876264
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		JOHANNES VERMEERPLEIN 9
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1071 DV
		BUSINESS PHONE:		31206645500

	MAIL ADDRESS:	
		STREET 1:		JOHANNES VERMEERPLEIN 9
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1071 DV

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LSP Cooperative UA
		DATE OF NAME CHANGE:	20210802
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001193125-24-029143</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001876264</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Ordinary Shares, par value CHF 0.10 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001953530</issuerCik>
        <issuerName>Oculis Holding AG</issuerName>
        <issuerCusip>H5870P102</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <street1 xmlns="http://www.sec.gov/edgar/common">Bahnhofstrasse 7</street1>
          <city xmlns="http://www.sec.gov/edgar/common">Zug</city>
          <stateOrCountry xmlns="http://www.sec.gov/edgar/common">V8</stateOrCountry>
          <zipCode xmlns="http://www.sec.gov/edgar/common">CH-6300</zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>LSP 7 Cooperatieve U.A.</reportingPersonName>
      <citizenshipOrOrganization>P7</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>5752894</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>5752894</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>5752894</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>13.8</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>LSP 7 Management B.V.</reportingPersonName>
      <citizenshipOrOrganization>P7</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>5752894</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>5752894</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>5752894</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>13.8</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Oculis Holding AG</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>Bahnhofstrasse 7, CH-6300, Zug, Switzerland.</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Each of the following is hereinafter individually referred to as a "Reporting Person" and collectively as the "Reporting Persons."  This statement is filed on behalf of:

LSP 7 Cooperatieve U.A. ("LSP 7"); and
LSP 7 Management B.V.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>The principal business address of each of the Reporting Persons is c/o EQT Life Sciences, Johannes Vermeerplein 9, 1071 DV Amsterdam, the Netherlands.</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Each of the Reporting Persons is organized under the laws of the Netherlands.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>The information contained on the cover pages to this Schedule 13G/A is hereby incorporated by reference into this Item 4. The ownership information presented herein represents beneficial ownership
of Ordinary Shares of the Issuer as of December 31, 2024, based on 41,745,295 Ordinary Shares outstanding as of September 6, 2024, as disclosed in the Issuer's Prospectus on Form 424B3 filed with
the Securities and Exchange Commission on September 6, 2024.

LSP 7 is the record holder of 5,752,894 Ordinary Shares.

LSP 7 Management B.V. is the sole director of LSP 7. The managing directors of LSP 7 Management B.V. are Martijn Kleijwegt, Rene Kuijten and Joachim Rothe. As such, LSP 7 Management B.V.,
Martijn Kleijwegt, Rene Kuijten and Joachim Rothe may be deemed to beneficially own the Ordinary Shares held of record by LSP 7. Each of Mr. Kleijwegt, Mr. Kuijten and Mr. Rothe disclaims beneficial
ownership of such shares.</amountBeneficiallyOwned>
        <classPercent>See Item 11 of each of the cover pages hereto.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>See Item 5 of each of the cover pages hereto.</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>See Item 6 of each of the cover pages hereto.</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>See Item 7 of each of the cover pages hereto.</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>See Item 8 of each of the cover pages hereto.</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>LSP 7 Cooperatieve U.A.</reportingPersonName>
      <signatureDetails>
        <signature>By: LSP 7 Management B.V., its managing director, /s/ Martijn Kleijwegt</signature>
        <title>Martijn Kleijwegt, Managing Director</title>
        <date>02/12/2025</date>
      </signatureDetails>
      <signatureDetails>
        <signature>By: LSP 7 Management B.V., its managing director, /s/ Rene Kuijten</signature>
        <title>Rene Kuijten, Managing Director</title>
        <date>02/12/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>LSP 7 Management B.V.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Martijn Kleijwegt</signature>
        <title>Martijn Kleijwegt, Managing Director</title>
        <date>02/12/2025</date>
      </signatureDetails>
      <signatureDetails>
        <signature>/s/ Rene Kuijten</signature>
        <title>Rene Kuijten, Managing Director</title>
        <date>02/12/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureComments>Material to be Filed as Exhibit:

Joint Filing Agreement:  https://www.sec.gov/Archives/edgar/data/1876264/000119312524029143/d550518dex99.htm</signatureComments>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
